National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 557260

History of Changes from the VAERS Wayback Machine

First Appeared on 12/14/2014

VAERS ID: 557260
VAERS Form:
Age:
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2014-12-08
Entered:2014-12-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / - UN / SYR

Administered by: Other      Purchased by: Other
Symptoms: Death

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:0000-00-00
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES1412USA003274

Write-up: This spontaneous report has been received from a consumer concerning 140 anonymous female patients of unknown age. On an unknown date patients were vaccinated with GARDASIL injection (dose/ dose in series/ route unknown). The reporter indicated that on an unspecified date, 140 anonymous women died after receiving GARDASIL. Cause of death was not reported. The reporter stated ''how many reported fatalities were needed for a product to be pulled from the market''. She further stated, ''with all of the side effects women experienced after receiving GARDASIL, Merck should not still be pushing the product and the product''s prescribing information needed to be updated''. The reporter indicated that she was seeking an attorney because ''Merck needs to update the GARDASIL prescribing information to include the 140 who have died because they received GARDASIL''. She enquired about the address for the Office of General Counsel. This is one of several reports received from the same reporter. Additional information has been requested.


Changed on 9/14/2017

VAERS ID: 557260 Before After
VAERS Form:(blank) 1
Age:
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2014-12-08
Entered:2014-12-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / - UNK UN / SYR

Administered by: Other      Purchased by: Other
Symptoms: Death

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:0000-00-00
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES1412USA003274

Write-up: This spontaneous report has been received from a consumer concerning 140 anonymous female patients of unknown age. On an unknown date patients were vaccinated with GARDASIL injection (dose/ dose in series/ route unknown). The reporter indicated that on an unspecified date, 140 anonymous women died after receiving GARDASIL. Cause of death was not reported. The reporter stated ''how many reported fatalities were needed for a product to be pulled from the market''. She further stated, ''with all of the side effects women experienced after receiving GARDASIL, Merck should not still be pushing the product and the product''s prescribing information needed to be updated''. The reporter indicated that she was seeking an attorney because ''Merck needs to update the GARDASIL prescribing information to include the 140 who have died because they received GARDASIL''. She enquired about the address for the Office of General Counsel. This is one of several reports received from the same reporter. Additional information has been requested.


Changed on 2/14/2018

VAERS ID: 557260 Before After
VAERS Form:1
Age:
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2014-12-08
Entered:2014-12-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / SYR

Administered by: Other      Purchased by: Other
Symptoms: Death

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:0000-00-00
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES1412USA003274

Write-up: This spontaneous report has been received from a consumer concerning 140 anonymous female patients of unknown age. On an unknown date patients were vaccinated with GARDASIL injection (dose/ dose in series/ route unknown). The reporter indicated that on an unspecified date, 140 anonymous women died after receiving GARDASIL. Cause of death was not reported. The reporter stated ''how many reported fatalities were needed for a product to be pulled from the market''. She further stated, ''with all of the side effects women experienced after receiving GARDASIL, Merck should not still be pushing the product and the product''s prescribing information needed to be updated''. The reporter indicated that she was seeking an attorney because ''Merck needs to update the GARDASIL prescribing information to include the 140 who have died because they received GARDASIL''. She enquired about the address for the Office of General Counsel. This is one of several reports received from the same reporter. Additional information has been requested.


Changed on 6/14/2018

VAERS ID: 557260 Before After
VAERS Form:1
Age:
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2014-12-08
Entered:2014-12-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / SYR

Administered by: Other      Purchased by: Other
Symptoms: Death

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:0000-00-00
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES1412USA003274

Write-up: This spontaneous report has been received from a consumer concerning 140 anonymous female patients of unknown age. On an unknown date patients were vaccinated with GARDASIL injection (dose/ dose in series/ route unknown). The reporter indicated that on an unspecified date, 140 anonymous women died after receiving GARDASIL. Cause of death was not reported. The reporter stated ''how many reported fatalities were needed for a product to be pulled from the market''. She further stated, ''with all of the side effects women experienced after receiving GARDASIL, Merck should not still be pushing the product and the product''s prescribing information needed to be updated''. The reporter indicated that she was seeking an attorney because ''Merck needs to update the GARDASIL prescribing information to include the 140 who have died because they received GARDASIL''. She enquired about the address for the Office of General Counsel. This is one of several reports received from the same reporter. Additional information has been requested.


Changed on 8/14/2018

VAERS ID: 557260 Before After
VAERS Form:1
Age:
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2014-12-08
Entered:2014-12-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / SYR

Administered by: Other      Purchased by: Other
Symptoms: Death

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:0000-00-00
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES1412USA003274

Write-up: This spontaneous report has been received from a consumer concerning 140 anonymous female patients of unknown age. On an unknown date patients were vaccinated with GARDASIL injection (dose/ dose in series/ route unknown). The reporter indicated that on an unspecified date, 140 anonymous women died after receiving GARDASIL. Cause of death was not reported. The reporter stated ''how many reported fatalities were needed for a product to be pulled from the market''. She further stated, ''with all of the side effects women experienced after receiving GARDASIL, Merck should not still be pushing the product and the product''s prescribing information needed to be updated''. The reporter indicated that she was seeking an attorney because ''Merck needs to update the GARDASIL prescribing information to include the 140 who have died because they received GARDASIL''. She enquired about the address for the Office of General Counsel. This is one of several reports received from the same reporter. Additional information has been requested.


Changed on 9/14/2018

VAERS ID: 557260 Before After
VAERS Form:1
Age:
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2014-12-08
Entered:2014-12-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / SYR

Administered by: Other      Purchased by: Other
Symptoms: Death

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:0000-00-00
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES1412USA003274

Write-up: This spontaneous report has been received from a consumer concerning 140 anonymous female patients of unknown age. On an unknown date patients were vaccinated with GARDASIL injection (dose/ dose in series/ route unknown). The reporter indicated that on an unspecified date, 140 anonymous women died after receiving GARDASIL. Cause of death was not reported. The reporter stated ''how many reported fatalities were needed for a product to be pulled from the market''. She further stated, ''with all of the side effects women experienced after receiving GARDASIL, Merck should not still be pushing the product and the product''s prescribing information needed to be updated''. The reporter indicated that she was seeking an attorney because ''Merck needs to update the GARDASIL prescribing information to include the 140 who have died because they received GARDASIL''. She enquired about the address for the Office of General Counsel. This is one of several reports received from the same reporter. Additional information has been requested.


Changed on 10/14/2018

VAERS ID: 557260 Before After
VAERS Form:1
Age:
Sex:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2014-12-08
Entered:2014-12-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / SYR

Administered by: Other      Purchased by: Other
Symptoms: Death

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:0000-00-00
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES1412USA003274

Write-up: This spontaneous report has been received from a consumer concerning 140 anonymous female patients of unknown age. On an unknown date patients were vaccinated with GARDASIL injection (dose/ dose in series/ route unknown). The reporter indicated that on an unspecified date, 140 anonymous women died after receiving GARDASIL. Cause of death was not reported. The reporter stated ''how many reported fatalities were needed for a product to be pulled from the market''. She further stated, ''with all of the side effects women experienced after receiving GARDASIL, Merck should not still be pushing the product and the product''s prescribing information needed to be updated''. The reporter indicated that she was seeking an attorney because ''Merck needs to update the GARDASIL prescribing information to include the 140 who have died because they received GARDASIL''. She enquired about the address for the Office of General Counsel. This is one of several reports received from the same reporter. Additional information has been requested.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=557260&WAYBACKHISTORY=ON


Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166